The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells.
about
Binding domain-driven intracellular trafficking of sterols for synthesis of steroid hormones, bile acids and oxysterolsBreast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells - A data descriptionAdjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies.An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell CarcinomaMcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications.Unexpected involvement of staple leads to redesign of selective bicyclic peptide inhibitor of Grb7.Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancerHerceptin resistance database for understanding mechanism of resistance in breast cancer patients.The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitriesDrug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment responseIntegrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies.Validation of analytical breast cancer microarray analysis in medical laboratory.The role of genes co-amplified with nicastrin in breast invasive carcinoma.3q26-29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes.Grb7 and Hax1 may colocalize partially to mitochondria in EGF-treated SKBR3 cells and their interaction can affect Caspase3 cleavage of Hax1HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors.NETBAGs: a network-based clustering approach with gene signatures for cancer subtyping analysis.SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes.Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification.
P2860
Q28241207-9BB939D4-CDFB-4CFD-A80C-8F452D1EF53DQ30245184-BC30ACD6-814B-42F3-A27B-DBF203E0C6EEQ31008419-3BEBEE45-F718-436A-B872-F89F1DB6F53EQ34010867-F7049C56-E4E6-4B75-BFE8-85741997F675Q35024073-7C5C7D22-0143-4FA8-9A2E-E96CC84D7729Q35663687-18192306-7ADE-42C8-8E6C-AE926E6D5209Q35805987-1FF070E7-2ABC-486E-9D9B-74C6BEDA3F2EQ35938054-DC01A35E-7AA7-41FF-964B-975D2DF491AEQ36964946-F36F2D65-4718-45D3-BD45-BD5037D14104Q37013995-4C8476E2-9C69-46D4-B4B2-83AF5727993DQ37636623-0C2D47F3-37C4-4C30-9BA7-B8D13F76F278Q37666730-A48F3231-F80D-4C7C-8955-0B831A9D3B97Q37710032-0B04FD0B-E1C9-46A6-A848-0B6687DA7CCCQ37722926-23E71F01-E5EE-42BF-A819-C4B0CBEBA49CQ37728699-C5C32853-F851-4E61-8412-EB23100A6DFDQ38382173-E6326CB4-92FD-428F-AFC7-F74F811FBB85Q38962113-68098672-B0F7-46A2-ACCF-B8BC4F394A44Q39043428-38BF9AC5-EF95-42BC-A102-B8588DBB5182Q39186868-B2EF73CF-8983-4CAA-977C-80C3530F59E1Q41771691-B4B85D73-DC32-41A9-A8B0-60F3250DD376Q48139829-584AA5A7-4384-40BD-B964-50E1A1DC26B3Q50786022-A9979042-AB88-47AC-860E-0EDB0A96557FQ55342016-FC10846F-10C0-4703-8DA9-31707F6C5C18Q55364226-CE35B0FC-3A80-473E-BC92-198B5B39FFD8
P2860
The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The HER2 amplicon includes sev ...... positive breast cancer cells.
@en
The HER2 amplicon includes sev ...... positive breast cancer cells.
@nl
type
label
The HER2 amplicon includes sev ...... positive breast cancer cells.
@en
The HER2 amplicon includes sev ...... positive breast cancer cells.
@nl
prefLabel
The HER2 amplicon includes sev ...... positive breast cancer cells.
@en
The HER2 amplicon includes sev ...... positive breast cancer cells.
@nl
P2093
P2860
P50
P1433
P1476
The HER2 amplicon includes sev ...... positive breast cancer cells.
@en
P2093
Henrik Edgren
Maija Wolf
Niko Sahlberg
Rami Mäkelä
Vesa Hongisto
P2860
P304
P356
10.1016/J.MOLONC.2012.10.012
P50
P577
2012-11-24T00:00:00Z